Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.579, 2009-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Long-term impact of androgen-deprivation therapy on physical function and quality of life
Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. :
Access to resources
Recommend
No long-term QOL benefit for CRT
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
Somatropin provides long-term QOL improvement in GHD
Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. :
Long-term androgen deprivation should be `standard treatment'
Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. :
Assessing the long-term impact of using HAART
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 312, 2001-01 ,pp. :